NCT03627377 Multi-component Intervention for Diabetes in Adults With Serious Mental Illness Status UNKNOWN Phase NA
NCT03627195 A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia Status COMPLETED Phase PHASE1
NCT03621540 Augmentation of Working Memory Training With Transcranial Direct Current Stimulation in Patients With Schizophrenia Status COMPLETED Phase NA
NCT03617783 Prebiotic Treatment in People With Schizophrenia - Pilot Study Status COMPLETED Phase PHASE4
NCT03608462 Modulation of Repetitive Transcranial Magnetic Stimulation on Hippocampal Neurogenesis and Functional Network in Patients With Schizophrenia Status UNKNOWN Phase NA
NCT03602716 High-Definition Transcranial Direct Current Stimulation as a Treatment of Negative Symptoms of Schizophrenia Status TERMINATED Phase NA
NCT03601026 Genetic Counselling in the Prevention of Mental Health Consequences of Cannabis Use Status RECRUITING Phase NA
NCT03593213 Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia Status TERMINATED Phase PHASE3
NCT03588728 tDCS and Cognitive Training Intervention for Chronic Smokers With Schizophrenia Status TERMINATED Phase NA
NCT03576976 Improving Accessibility and Personalization of CR for Schizophrenia Status COMPLETED Phase NA
NCT03576911 A Randomised Controlled Trial of Coenzyme Q10 in Patients With Schizophrenia and Schizoaffective Disorder Status UNKNOWN Phase NA
NCT03575000 Bromocriptine for Patients With Schizophrenia and Prediabetes Status NOT_YET_RECRUITING Phase PHASE4
NCT03568500 A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic Status COMPLETED Phase PHASE4
NCT03565068 A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007) Status COMPLETED Phase PHASE1